Greg  Lanza

Greg Lanza

Professor of Medicine

Washington University

Gregory M. Lanza, MD, Ph.D founded Kereos, Inc. in 1999 and serves as its Chief Scientific Officer. Dr. Lanza served as Research Manager of Monsanto Company, St. Louis where he directed pre-clinical development of bovine somatotropin (Posilac). He serves as Assistant Professor of Medicine and Biomedical Engineering of Washingtion University, and is on the Barnes-Jewish Hospital staff. He served as Director of Kereos, Inc. since 1999. Among various other honors, he has received multiple National Cancer Institute's Unconventional Innovation Program Awards. His research has focused on site-targeted therapeutics and contrast agents for both cancer and cardiovascular diease, and he is the author of over 80 publications. Dr. Lanza holds an M.D. degree from Northwestern University, a Ph.D and MS in Genetics from the University of Georgia, and a BA in Biology from Colby College.

Sponsor & Exhibitor Opportunities

 Exhibit and Showcase
 Become a Sponsor

Please contact: Denise Lee


Program Tracks

Fabrication & Characterization

Advanced Materials

Electronics & Microsystems

Medical & Biotech

Energy & Environment

Business & Partnering

 

In Partnership with

NSTI


2012 TechConnect Corporate Acceleration Partners:

AC-NET
Applied Materials
Austin_Energy
BASF
BayerMaterialScience
bp
ConstellationEnergy
DOW
Fraunhofer TechBridge
Hitachi
Honda
IBM
Kauffman Foundation
Kodak
Lam
Lockheed Martin
MWV
nationalgrid
NortheastUtilities
novaris
Panasonic
PPG
Samsung
schlumberger
Shell_GameChanger
siemens
SK Innovation
SouthernCalEdison
Toray
Sponsorship Opportunities: Contact Denise Lee

Free Subscription

E-mail:

pbh(); ?>